RxDoctor Payments Data

William Livingston, MD

Otolaryngology · Alabaster, ALNPI 1043233091

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.8% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Optinose US, Inc. at 30.6% of the total. 2025 is the largest year on record at $888, 2.5 times the $358 reported in 2019.

$3,174in general payments, 2019–2025

Across 121 payments — averaging $26.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$971
  • Sanofi$386
  • Intersect ENT, Inc.$366
  • Regeneron Healthcare Solutions, Inc.$342
  • GSK$208
  • Inspire Medical Systems, Inc.$132
  • plus $770 from 14 others

What the payments were for

  • Food & beverage$3,04296%
  • Education$1324%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,174 in reported general payments places this provider in the 70th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$131,728
Medicare patients
384
Services billed
1,165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pilocarpine Hcl156$8,518
Azelastine Hcl156$4,889
Ipratropium Bromide132$3,954
Fluticasone Propionate271$3,829
Fluocinolone Acetonide Oil78$3,786
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth34$3,639
Mometasone Furoate50$3,351
Ofloxacin73$2,727
Montelukast Sodium167$2,202
Nystatin42$1,395
Clarithromycin36$1,298
Levocetirizine Dihydrochloride72$1,100
CefuroximeCefuroxime Axetil66$1,044
Prednisone382$1,024
Triamcinolone Acetonide29$908

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Alabaster

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →